Chemical Compound
Budesonide Imp. I (EP); (11beta,16alpha)-11,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16-yl Butyrate; (11beta,16alpha)-11,17,21-trihydroxy-16-(1-oxobutoxy)-pregna-1,4-diene-3,20-dione; 16alpha-(Butyryloxy)prednisolone; 16alpha-Hydroxyprednisolone 16-butyrate; 11beta,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16alpha-yl Butanoate; 16alpha-Butyloxyprednisolone; Budesonide Impurity I
CAS Registry Number
113930-13-5
Primary record
Budesonide Imp. I (EP); (11beta,16alpha)-11,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16-yl Butyrate; (11beta,16alpha)-11,17,21-trihydroxy-16-(1-oxobutoxy)-pregna-1,4-diene-3,20-dione; 16alpha-(Butyryloxy)prednisolone; 16alpha-Hydroxyprednisolone 16-butyrate; 11beta,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16alpha-yl Butanoate; 16alpha-Butyloxyprednisolone; Budesonide Impurity I
- 库存
- 1,689 克
- 纯度
- 98.6 %
- CAS
- 113930-13-5
化合物标识与属性
- CAS
- 113930-13-5
- PubChem CID
- 129318440
- SMILES
- CCCC(=O)O[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@H]3[C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)C
- Canonical SMILES
- CCCC(=O)O[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
名称与同义词
- Budesonide Impurity I
- Budesonide EP Impurity I
- Y8WU33GU4G
- Budesonide impurity I [EP]
- UNII-Y8WU33GU4G
- 16alpha-(Butyryloxy)prednisolone
- 16-Butyryloxyprednisolone
- RefChem:197153
- 16alpha-Butyloxyprednisolone
- 113930-13-5
- CHEMBL4525798
- 16alpha-Hydroxyprednisolone 16-butyrate
- MNVQDRXNQLFAHB-OTUUEPHNSA-N
- 16a-Butyloxyprednisolone(Budenoside Impurity)
- BUDESONIDE IMPURITY I [EP IMPURITY]
- FB146161
- CID 129318440
- 16.ALPHA.-(BUTYRYLOXY)PREDNISOLONE
- BUDESONIDE IMPURITY I (EP IMPURITY)
- 16alpha-Butyloxyprednisolone(Budenoside Impurity)
- 16-Butyloxyprednisolone (Budenoside IMpurity)
- 16.ALPHA.-HYDROXYPREDNISOLONE 16-BUTYRATE
- 11beta,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16alpha-yl Butanoate
- 16alpha-Butyloxyprednisolone (Budenoside IMpurity)
- (11beta,16alpha)-11,17,21-Trihydroxy-16-(1-oxobutoxy)pregna-1,4-diene-3,20-dione
- Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-16-(1-oxobutoxy)-, (11beta,16alpha)-
- [(8S,9S,10R,11S,13S,14S,16R,17S)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl] butanoate
- 11.BETA.,17,21-TRIHYDROXY-3,20-DIOXOPREGNA-1,4-DIEN-16.ALPHA.-YL BUTANOATE
- (11.BETA.,16.ALPHA.)-11,17,21-TRIHYDROXY-16-(1-OXOBUTOXY)PREGNA-1,4-DIENE-3,20-DIONE
- PREGNA-1,4-DIENE-3,20-DIONE, 11,17,21-TRIHYDROXY-16-(1-OXOBUTOXY)-, (11.BETA.,16.ALPHA.)-
- (8S,9S,10R,11S,13S,14S,16R,17S)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-16-yl butyrate
- Budesonide Imp. I (EP); (11beta,16alpha)-11,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16-yl Butyrate; (11beta,16alpha)-11,17,21-trihydroxy-16-(1-oxobutoxy)-pregna-1,4-diene-3,20-dione; 16alpha-(Butyryloxy)prednisolone; 16alpha-Hydroxyprednisolone 16-butyrate; 11beta,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16alpha-yl Butanoate; 16alpha-Butyloxyprednisolone; Budesonide Impurity I